Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection
Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1 ...
Drug Store News16h
Dr. Reddy’s sells 14 generic non-strategic assets to Senores Pharma for U.S. expansion
The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval.
ConsumerAffairs1d
Dr. Reddy’s recalls levetiracetam infusion bags nationwide due to mislabeling
Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 ...
Dr Reddy’s recalls Levetiracetam Sodium Chloride Injection in US market
Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...
Dr. Reddy’s recalls mislabelled seizure injection Levetiracetam in U.S. to consumer level
Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the ...
CNBCTV181d
Dr Reddy’s recalls epilepsy drug in US over mislabeling concerns
The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...
Dr. Reddy’s recalls mislabelled Levetiracetam injection in the US; patients likely to experience 'adverse' events
Dr. Reddys Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...
Dr. Reddy's Laboratories rises Thursday, outperforms competitors
Dr. Reddy's Laboratories Ltd. closed 21.99% below its 52-week high of 1,420.20 rupees, which the company reached on August ...
Stock market today: Dr. Reddy’s to Yes Bank— 274 BSE-listed shares hit 52-week low. Do you own any?
The stock market experienced declines on March 12, with Dr. Reddy’s Laboratories and others reaching yearly lows due to US ...
Dr. Reddy's Laboratories slips Wednesday, underperforms market
Dr. Reddy's Laboratories Ltd. closed 22.18% short of its 52-week high of 1,420.20 rupees, which the company reached on August 21st.
ALS drug failures and why COYA 302 is different
ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...